Loading...
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
BACKGROUND: Three classes of inhaler medication are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta₂‐agonists (LABA); long‐acting muscarinic antagonists (LAMA); and inhaled corticosteroids (ICS). To encourage patient adherence, two classes of medication are often combin...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2018
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513478/ https://ncbi.nlm.nih.gov/pubmed/30141826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012355.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|